![]() |
| [
Home |
Editorial |
Aims and Scope |
Table of Contents |
Archive |
Search |
Introductions to Authors |
Contact ] [ Copyright Transfer Form | Subscription Form ] |
| Journal of Retina-Vitreous |
| 2010, Volume 18, Number 2, Page(s) 163-166 |
| [ Turkish ] [ Full text PDF ] [ Similar Articles ] [ E-Mail to Author ] |
| Intravitreal Bevacizumab in a Case of Choroidal Neovascularization Associated with Punctate Inner Choroidopathy |
| Fehmi Cem KÜÇÜKERDÖNMEZ1, Yonca AKOVA2, Sibel AKSOY3, Yüksel SÜLLÜ4 |
| 1Başkent Üniversitesi Tıp Fakültesi, Göz Hastalıkları A.D., Ankara, Uzm. Dr. 2Başkent Üniversitesi Tıp Fakültesi, Göz Hastalıkları A.D., Ankara, Prof. Dr. 3Başkent Üniversitesi Tıp Fakültesi, Göz Hastalıkları A.D., Ankara, Asist. Dr. 4Ondokuz Mayıs Üniversitesi Tıp Fakültesi, Göz Hastalıkları A.D., Samsun, Prof. Dr. |
| Keywords: bevacizumab, choroidal neovascularization, punctate inner choroidopathy |
|
Punctate inner choroidopathy is an idiopathic, inflammatory disorder that is characterized by yellowish white spots at the level of retina pigment epithelium and inner choroid. It is associated with a high incidence of choroidal neovascularization (CNV). Vision loss occurs mainly due to CNV development, and treatment options include systemic steroids, laser photocoagulation, interferon β1α, and submacular surgery. We report a case of punctate inner choroidopathy and discuss the results of intravitreal bevacizumab treatment for CNV.
|
| [ Turkish ] [ Full text PDF ] [ Similar Articles ] [ E-Mail to Author ] |
| [
Home |
Editorial |
Aims and Scope |
Table of Contents |
Archive |
Search |
Introductions to Authors |
Contact ] [ Copyright Form | Subscription Form ] |